tients with poor left ventricular function and multivessel disease.1-9 Both randomized and nonrandomized trials have documented this improved survival in such patients with both stable and unstable angina.1,3-6 The role tients undergoing PTCA in the setting of acute myocardial infarction were excluded from this analysis. Among the 1,802 patients, the ejection fraction was <45% in 244 (13.5%) and >45% in 1,211 (67%). These two patient groups form the basis of this report. In the remaining 347 patients (19%), ejection fraction data were not made available to the central coordinating center.
Definitions
Assessment of baseline left ventricular function was done at each center but was not dictated by a common prospective protocol. Techniques for assessment included left ventricular angiography, radionuclide angiography, and echocardiography.
Vessel disease was classified as one-, two-, or threevessel disease according to Differences in proportion between patient groups were analyzed by the x2 test or by Fisher's exact test when the number of patients in a group was small. Event-free survival was assessed by the product-limit (Kaplan-Meier) method; the end points were death; death and myocardial infarction; and death, myocardial infarction, and coronary artery bypass grafting. Independent factors associated with follow-up events were identified with Cox regression analysis using the maximal partial likelihood ratio method. 16 The relative risk of an event for patients with left ventricular dysfunction compared with the risk in those with well-preserved left ventricular function was estimated. The 95% confidence interval of each risk was also determined. When the confidence interval did not include unity, the equal risk hypothesis was rejected. Probability values <0.05 were considered statistically significant. Results Among the 244 patients (13.5%) with an ejection fraction of 545% (group 1), the mean ejection fraction was 39.6+6.8% (range, 10-45%). Most patients in group 1 had an ejection fraction between 36% and 45% (193 patients, 79%), 40 patients (16%) had an ejection fraction from 25% to 35%, and 11 patients (5%) had an ejection fraction <25% (Table 1 ). In comparison, among the 1,211 patients (67%) with an ejection fraction >45% (group 2), the average ejection fraction was 62.8+8.7% (range, 46-91%) (Figure 1 ). The two groups had significant differences in baseline characteristics (Table 1 ) and the degree of severity of coronary artery disease (Table 2) . More 67% of group 1 patients were alive and had not had coronary artery bypass grafting or a myocardial infarction.
The long-term outcomes of the subgroups of patients with ejection fractions of .45% (<25%, 25-35%, 36-45%) were also compared with the outcomes of patients with ejection fractions >45% (Table 4) . Despite the small numbers of patients with markedly depressed left ventricular function, there were significant trends; longterm outcome was poorer in patients with more severe left ventricular dysfunction (Figure 3 ). The cumulative mortality at 4 years was 6.9% in patients with an ejection fraction >45% and 54.5% in the small number of patients with an ejection fraction <25%. At Another method used to assess whether ejection fraction as a discrete variable has a significant association with subsequent untoward events was Cox regression analyses; for these, death, death and myocardial infarction, and the combined end points of death, myocardial infarction, and coronary artery bypass grafting were used. For patients with an ejection fraction of .45%, the risk of dying in 4 years was approximately twice as high as that in patients with an ejection fraction >45% (Table 5) .
We also assessed ejection fraction as a continuous variable with a decreasing scale of 5% units. For every 5% decrease in ejection fraction, there was an unadjusted mortality risk of 1.2% and an adjusted mortality risk of 1.11% (Table 6) .
Multivariate analysis was performed to determine whether left ventricular dysfunction is itself an independent risk factor or whether differences in the baseline risk factors in the two groups were the major reason for the difference in mortality. The relative risks of the factors that were strongly associated with the 4-year events are shown in In the multicenter NHLBI registry data accumulated for [1985] [1986] , patients with an ejection fraction of .45% (group 1), as expected, had significantly more advanced disease with higher rates of prior infarction, prior coronary artery bypass grafting, congestive heart failure, total occlusion, and three-vessel disease than patients with more well-preserved left ventricular function (group 2). Despite these differences in baseline and angiographic variables, at least one lesion in which PTCA was attempted was successfully dilated in 88% of group tThe Cox model for death, MI, or CABG was adjusted by history of diabetes, history of congestive heart failure, Canadian cardiovascular class 3 or 4, unstable angina, clinical success, and incomplete revascularization. 
Conclusions
These multicenter data document the efficacy of PTCA in selected patients with suitable angiographic anatomy but depressed left ventricular function. In these selected patients, initial outcome and the riskbenefit ratio were excellent. There was no difference in the in-hospital rates of death or nonfatal infarction between the patients with reduced left ventricular function and those with preserved left ventricular function. At least one lesion was successfully dilated in 88% of patients with abnormal left ventricular function and in 91% of patients with normal function (nonsignificant difference). However, the former group had decreased frequencies of successful dilation in all lesions attempted, of successful dilation of the left anterior descending artery, and of complete revascularization. During long-term follow-up, depressed left ventricular dysfunction was associated with a significantly higher mortality rate even after adjustment for other important variables such as older age, a history of diabetes mellitus or congestive heart failure, clinical success, and presence of multivessel disease, which were simultaneously present. Despite this difference, among these patients with a mean ejection fraction of 39%, at 4 years 87% remained alive, and 67% were alive and had not had a myocardial infarction or required coronary artery bypass grafting.
